Survival Trends and Long-Term Toxicity in Pediatric Patients with Osteosarcoma

por Hagleitner, Melanie M., de Bont, Eveline S. J. M., te Loo, D. Maroeska W. M.
Publicado 2012

Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review

por Hurkmans, Evelien G. E., Brand, Annouk C. A. M., Verdonschot, Job A. J., te Loo, D. Maroeska W. M., Coenen, Marieke J. H.
Publicado 2022

The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma

por Fleuren, Emmy D.G., Hillebrandt-Roeffen, Melissa H.S., Flucke, Uta E., te Loo, D. Maroeska W.M., Boerman, Otto C., van der Graaf, Winette T.A., Versleijen-Jonkers, Yvonne M.H.
Publicado 2014

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care

por Dittrich, Anne T. M., Smeets, Nori J. L., de Jong, Emma F. M., Kämink, Juliët L., Kroeze, Yvet, Draaisma, Jos M. Th., van Puijenbroek, Eugène P., te Loo, D. Maroeska W. M.
Publicado 2022

Contribution of common and rare genetic variants in CEP72 on vincristine‐induced peripheral neuropathy in brain tumour patients

por Klumpers, Marije J., Brand, Annouk C. A. M., Hakobjan, Marina, Gattuso, Giovanna, Schiavello, Elisabetta, Terenziani, Monica, Massimino, Maura, Gidding, Corrie E. M., Guchelaar, Henk‐Jan, te Loo, D. Maroeska W. M., Coenen, Marieke J. H.
Publicado 2022

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities

por Hurkmans, Evelien G. E., Klumpers, Marije J., Vermeulen, Sita H., Hagleitner, Melanie M., Flucke, Uta, Schreuder, H. W. Bart, Gelderblom, Hans, Bras, Johannes, Guchelaar, Henk-Jan, Coenen, Marieke J. H., te Loo, D. Maroeska W. M.
Publicado 2020

Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney Injury

por Klumpers, Marije J., Witte, Ward De, Gattuso, Giovanna, Schiavello, Elisabetta, Terenziani, Monica, Massimino, Maura, Gidding, Corrie E. M., Vermeulen, Sita H., Driessen, Chantal M., van Herpen, Carla M., van Meerten, Esther, Guchelaar, Henk-Jan, Coenen, Marieke J. H., te Loo, D. Maroeska W. M.
Publicado 2022

Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus

por Harbers, Veroniek E. M., Bouwman, Frédérique C. M., van Rijnsoever, Ingrid M. P., Verhoeven, Bas H., van der Vleuten, Carine J. M., Schultze Kool, Leo J., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Kievit, Wietske, te Loo, D. Maroeska W. M.
Publicado 2023

Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations – A nationwide trial

por Harbers, Veroniek E. M., Zwerink, Lilly G. J. M., Rongen, Gerard A., Klein, Willemijn M., van der Vleuten, Carine J. M., van Rijnsoever, Ingrid M. P., Gerdsen‐Drury, Lynda, Flucke, Uta E., Verhoeven, Bas H., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Schultze Kool, Leo J., te Loo, D. Maroeska W. M.
Publicado 2023

Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia

por Hurkmans, Evelien G. E., Klumpers, Marije J., Dello Russo, Cinzia, De Witte, Ward, Guchelaar, Henk-Jan, Gelderblom, Hans, Cleton-Jansen, Anne-Marie, Vermeulen, Sita H., Kaal, Suzanne, van der Graaf, Winette T. A., Flucke, Uta, Gidding, Corrie E. M., Schreuder, Hendrik W. B., de Bont, Eveline S. J. M., Caron, Huib N., Gattuso, Giovanna, Schiavello, Elisabetta, Terenziani, Monica, Massimino, Maura, McCowage, Geoff, Nagabushan, Sumanth, Limaye, Anuja, Rose, Victoria, Catchpoole, Daniel, Jorgensen, Andrea L., Barton, Christopher, Delaney, Lucy, Hawcutt, Daniel B., Pirmohamed, Munir, Pizer, Barry, Coenen, Marieke J. H., te Loo, D. Maroeska W. M.
Publicado 2023

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

por Hurkmans, Evelien G. E., Koenderink, Jan B., van den Heuvel, Jeroen J. M. W., Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Groothuismink, Johanne M., Vos, Hanneke I., van der Graaf, Winette T. A., Flucke, Uta, Muradjan, Grigor, Schreuder, Hendrik W. B., Hagleitner, Melanie M., Brunner, Han G., Gelderblom, Hans, Cleton-Jansen, Anne-Marie, Guchelaar, Henk-Jan, de Bont, Eveline S. J. M., Touw, Daan J., Nijhoff, G. Jan, Kremer, Leontien C. M., Caron, Huib, Windsor, Rachael, Patiño-García, Ana, González-Neira, Anna, Saletta, Federica, McCowage, Geoff, Nagabushan, Sumanth, Catchpoole, Daniel, te Loo, D. Maroeska W. M., Coenen, Marieke J. H.
Publicado 2022